Meoni P - Search Results

1

Economic Evaluations of Pharmacogenetic Approaches in Infectious Diseases: A Review of Current Approaches and Evaluation of Critical Aspects Affecting their Quality.

Meoni P. Meoni P. J Public Health Afr. 2013 Nov 25;4(2):e18. doi: 10.4081/jphia.2013.e18. eCollection 2013 Dec 3. J Public Health Afr. 2013. PMID: 28299107 Free PMC article. Review.

2

Review of existing experimental approaches for the clinical evaluation of the benefits of plant food supplements on cardiovascular function.

Meoni P, Restani P, Mancama DT. Meoni P, et al. Food Funct. 2013 Jun;4(6):856-70. doi: 10.1039/c3fo30323c. Epub 2013 May 15. Food Funct. 2013. PMID: 23673390 Free article. Review.

3

Investigation of in vitro and in vivo anti-asthmatic properties of Siphonochilus aethiopicus.

Fouche G, Nieuwenhuizen N, Maharaj V, van Rooyen S, Harding N, Nthambeleni R, Jayakumar J, Kirstein F, Emedi B, Meoni P. Fouche G, et al. Among authors: meoni p. J Ethnopharmacol. 2011 Jan 27;133(2):843-9. doi: 10.1016/j.jep.2010.11.014. Epub 2010 Nov 11. J Ethnopharmacol. 2011. PMID: 21075193

4

Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.

Meoni P, Hackett D, Lader M. Meoni P, et al. Depress Anxiety. 2004;19(2):127-32. doi: 10.1002/da.10141. Depress Anxiety. 2004. PMID: 15022148 Clinical Trial.

5

Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.

Pollack MH, Meoni P, Otto MW, Simon N, Hackett D. Pollack MH, et al. Among authors: meoni p. J Clin Psychopharmacol. 2003 Jun;23(3):250-9. doi: 10.1097/01.jcp.0000084025.22282.84. J Clin Psychopharmacol. 2003. PMID: 12826987

6

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.

Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D. Davidson JR, et al. Among authors: meoni p. Depress Anxiety. 2002;16(1):4-13. doi: 10.1002/da.10045. Depress Anxiety. 2002. PMID: 12203668

7

Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

Montgomery SA, Sheehan DV, Meoni P, Haudiquet V, Hackett D. Montgomery SA, et al. Among authors: meoni p. J Psychiatr Res. 2002 Jul-Aug;36(4):209-17. doi: 10.1016/s0022-3956(02)00005-5. J Psychiatr Res. 2002. PMID: 12191625

8

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

Meoni P, Salinas E, Brault Y, Hackett D. Meoni P, et al. J Clin Psychiatry. 2001 Nov;62(11):888-93. doi: 10.4088/jcp.v62n1109. J Clin Psychiatry. 2001. PMID: 11775049 Clinical Trial.

9

Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.

Mugnaini M, Meoni P, Bunnemann B, Corsi M, Bowery NG. Mugnaini M, et al. Among authors: meoni p. Br J Pharmacol. 2001 Apr;132(8):1883-97. doi: 10.1038/sj.bjp.0704017. Br J Pharmacol. 2001. PMID: 11309261 Free PMC article.

10

NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson's disease patients.

Meoni P, Bunnemann BH, Kingsbury AE, Trist DG, Bowery NG. Meoni P, et al. Neuropharmacology. 1999 May;38(5):625-33. doi: 10.1016/s0028-3908(98)00219-6. Neuropharmacology. 1999. PMID: 10340300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters